First-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CT.

JSON

Bjäreback A, Jonmarker O, Tzortzakakis A, Jussing E, Li C, Altena R, Hindorf C, Orlova A, Axelsson R, Tran TA

EJNMMI Res 15 (1) 12 [2025-02-20; online 2025-02-20]

PubMed 39976803

DOI 10.1186/s13550-025-01204-y

Crossref 10.1186/s13550-025-01204-y

pmc: PMC11842642
pii: 10.1186/s13550-025-01204-y